Hepregen

How does the HepatoPac™ platform compare to conventional in vitro methods for liver metabolism and toxicity testing? Download this informative white paper
to see how HepatoPac™ can benefit you.

Get the latest on the microliver platform
that’s transforming metabolism and toxicity testing

Everyone’s talking about HepatoPac™, the novel microliver platform that offers a whole new direction in liver metabolism and toxicity testing. HepatoPac’s long-term stability of 4-6 weeks allows in vivo-level predictability in an in vitro format, giving you an innovative yet practical method to better prioritize and select compounds-so you can reduce your attrition rate.

Join the conversation. Simply click on a link below to register for an event,
or download our latest white paper.

Upcoming Events

• MAY

  21

  May 21-22, 2012

  SACHS SPI 2012: Science, Partnering and Investment Forum

  President and CEO Bonnie Fendrock will present on Monday, May 21, 2012 at 10:30 am in Ballroom B of the Palm Beach County Convention Center.

• JUN

  5

  June 5-7, 2012

  CHI 11th Annual World Pharma Congress

  Dr. Okey Ukairo, Senior Principal Scientist, ADME/Tox Services will present poster “A MICROPATTERNED CULTURE WITH HUMAN HEPATOCYTES AND KUPFFER MACROPHAGES FOR STUDYING INFLAMMATION-DRUG INTERACTIONS” available for viewing Tuesday, June 5, 2012 at 3:40 pm in the Exhibit Hall of the Loews Philadelphia Hotel.

• JUN

  15

  June 14-15, 2012

  ISC ETS-2012: 10th International Conference

  Dr. Okey Ukairo, Senior Principal Scientist, ADME/Tox Services will present “A Novel Micropatterened Hepatocyte Co-culture System for Drug Metabolism and Toxicity Studies” on Friday, June 15, 2012 at 4:30 pm in the Emerald Ballroom 1 of the Red Lion Hotel.

• OCT

  14

  October 14-18, 2012

  18th North American Regional ISSX Meeting

  Hepregen Corporation will be exhibiting at this event hosted in the Hilton Anatole Dallas Hotel. Check back soon for more details.